Publication | Closed Access

Modulation of NF-κB activation by resveratrol in LPS treated human intestinal cells results in downregulation of PGE2 production and COX-2 expression

InflammationPge2 ProductionGastrointestinal PharmacologyImmunologyImmune RegulationChronic InflammationPathologyGut-organ AxisNf-κb ActivationCox-2 ExpressionGut BarrierMetabolic SignalingMedicineCell BiologyCell SignalingOxidative Stress